Portage Biotech Inc. (PRTG): TORONTO, Dec. 6, 2018 /PRNewswire/ - (PB...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Portage Biotech Inc. (PRTG)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	3395
Boards Moderated	0
Alias Born	10/20/2005

Re: None

Thursday, 12/06/2018 10:26:23 PM

Thursday, December 06, 2018 10:26:23 PM

TORONTO, Dec. 6, 2018 /PRNewswire/ - (PBT.U: CSE, PTGEF: OTC Markets) – Further to its news release of November 27, 2018, Portage Biotech Inc. ("Portage" or the "Company") is pleased to announce that its common shares will resume trading at the open on CSE tomorrow, December 7, 2018 with trading on OTC expected to resume shortly thereafter.

The mailing of shareholder meeting materials regarding the acquisition of SalvaRx Limited from SalvaRx Group plc has been completed. Copies of the meeting materials have been posted to SEDAR, the CSE website and Portage's corporate website.

Completion of the SalvaRx acquisition remains subject to shareholder and CSE approval.

------------------------------------------------------------------

Once again, I'm a bit confused with this release. It says that "OTC expected to resume shortly thereafter". Does this mean tomorrow (the 7th)? Or, a later date? Wish they would give an exact date. The "shortly thereafter" can be construed in different ways. But, I'm guessing that it will be tomorrow.....FINALLY.

Really curious as to what direction the shares will be headed. I think north.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PRTG News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/01/2024 08:31:28 PM
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives • GlobeNewswire Inc. • 04/12/2024 12:01:00 PM
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares • GlobeNewswire Inc. • 03/26/2024 12:01:13 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 10:30:43 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 10:04:30 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/28/2024 10:19:51 PM
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update • GlobeNewswire Inc. • 02/28/2024 10:10:19 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:50:16 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/18/2024 10:09:11 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 01:10:06 PM
Portage Biotech Reports Business and Strategic Update • GlobeNewswire Inc. • 01/04/2024 01:00:37 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/01/2023 09:05:45 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/28/2023 09:03:19 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 09:02:08 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 09:01:24 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/14/2023 11:00:29 AM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 11:10:09 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/08/2023 05:15:28 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/07/2023 09:50:10 PM
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 11/06/2023 01:01:00 PM
Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 10/31/2023 08:05:49 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/29/2023 12:01:11 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/08/2023 08:01:10 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2023 12:00:18 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2023 08:01:47 PM

More PRTG News

InvestorsHub NewsWire

North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM

Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM

Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM

POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow